Pharmacy-based Point-of-Care Testing Certificate Program

May 12 9 a.m. – 1 p.m. ET
June 23 9 a.m. – 1 p.m. ET (Registration opens May 7)

Program Information

The NASPA Pharmacy-based Point-of-Care Testing Certificate Program provides an
opportunity to gain the skills and information necessary to develop a testing program for coronaviruses, influenza,
Group A Streptococcus, HIV, and Hepatitis C. The target is pharmacists, pharmacy technicians, and student pharmacists.

The 20-hour ACPE-accredited certificate program includes comprehensive material regarding key
disease states, physical assessment, point-of-care tests, collaborative practice models, and business
models through:

  • 16 hours of home study

  • Up to 4 hours of live training

  • 15 minute skills assessment based on your availability (a few basic supplies needed)

Students take an online assessment after each of the 12 modules of home study, in addition to a
cumulative assessment (must pass 70% within three attempts), and then their proficiency to conduct
physical assessments and offer point-of-care testing services is assessed in the live training. Upon
successful completion of both portions of the program and all program evaluations, participants are
awarded a certificate of completion and pharmacists can receive 20 hours of Continuing Pharmacy
Education (CPE) credit.

Learning Objectives

At the completion of this activity, the pharmacist will be able to:

  • Identify at least 3 opportunities for expanding patient-centered services in the community pharmacy setting, using point of care

  • Discuss the value and limitations of patient reported symptoms, medical history, and drug allergies

  • Describe and perform the following physical assessments, when appropriate to patient care: Blood Pressure, Pulse, Respiratory Rate, Oxygenation, Cervical Lymph Node Inspection, Body Temperature

  • Describe and perform the following specimen collections used in point of care testing: Throat swab, Oral fluid collection, Nasal swab, Finger stick

  • Identify characteristics of the five exemplar infectious diseases (influenza, Group A Streptococcus, Human Immunodeficiency Virus, Hepatitis C, Coronaviruses) regarding: Causative agents, Transmission, Immunizations, Symptoms and Presentation, Appropriate therapy, Point-of-Care testing

  • Define and contrast the following terms as they relate to point-of-care testing in community pharmacies: CLIA, CLIA-waived, Collaborative Agreement, Protocol, Prescribe, Diagnose

  • Explain the value and limitations of Point-of-Care Tests, including rapid diagnostic tests, and list the steps a pharmacist can take to improve test performance

  • Apply all information to patient-specific cases based on common community pharmacy-based patient interaction

At the completion of this activity, the pharmacy technician will be able to:

  • Identify at least 3 opportunities for expanding patient-centered services in the community pharmacy setting, using point of care

  • Discuss the value and limitations of patient reported symptoms, medical history, and drug allergies

  • Describe and perform the following physical assessments, when appropriate to patient care: Blood Pressure, Pulse, Respiratory Rate, Oxygenation, Cervical Lymph Node Inspection, Body Temperature

  • Describe and perform the following specimen collections used in point of care testing: Throat swab, Oral fluid collection, Nasal swab, Finger stick

  • Identify signs, symptoms, and characteristics of the five exemplar infectious diseases (influenza, Group A Streptococcus, Human Immunodeficiency Virus, Hepatitis C, Coronaviruses) where POCT may be relevant

  • Define and contrast the following terms as they relate to point-of-care testing in community pharmacies: CLIA, CLIA-waived, Collaborative Agreement, Protocol, Prescribe, Diagnose

  • Explain the value and limitations of Point-of-Care Tests, including rapid diagnostic tests, and list the steps a pharmacist can take to improve test performance

  • Apply all information to patient-specific cases based on common community pharmacy-based patient interactions

Speakers:
Kevin Day, PharmD, owner, President, Day’s Miami Heights Pharmacy, Cincinnati, Ohio
John Beckner, RPh, NCPA Senior Director of Strategic Initiatives, Alexandria, Va.

Questions? Email Bri Morris, PharmD at Bri.Morris@ncpa.org.

ACPEMichigan Pharmacists Association is accredited by the Accreditation Council for Pharmacy Education (ACPE) as a provider of continuing pharmacy education.

Credit is only awarded for completion of the entire 20 contact hour program. Credit must be claimed within 60 days of completing the program.

Pharmacy-based Point-of-Care Testing Certificate Program

ACPE Universal Activity #0112-0000-21-112-B04-P | 0112-0000-21-112-B04-T.
Activity Type: Practice-based
Target Audience: Pharmacists and pharmacy technicians in all practice settings
Release Date: February 4, 2021
Expiration Date: February 4, 2024

Contact Hours: 20.0

Minimum System Requirements
Processor: 1GHz | Hard Drive: 32 GB | Memory (RAM): 1 GB | Sound card with speakers | Internet Access: 10 Mbps download

Supported Browsers
Latest Chrome Version | Latest Firefox Version | Latest Edge Version | Latest Safari Version | Internet Explorer 11